NPPA slashes cancer drug MRPs by up to 93%; Thiotepa cut by ₹72,921
Summary
The drug pricing regulator has slashed retail prices of 543 formulations across 137 non-scheduled cancer medicines, with some cuts exceeding 90% under a trade margin rationalisation framework.
Description from Livemint.
Who is covering this
-
NPPA slashes cancer drug MRPs by up to 93%; Thiotepa cut by ₹72,921
The drug pricing regulator has slashed retail prices of 543 formulations across 137 non-scheduled cancer medicines, with some cuts exceeding 90% under a trade margin rationalisation framework.
